×
For best experience we recommend to activate Javascript in your browser.
Recombinant IL4 (Pascolizumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL4 (Pascolizumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL4 (Pascolizumab Biosimilar) in samples from Human.
Catalog No. ABIN7487819
$336.06
Plus shipping costs $50.00
1 mg ABIN7446089
100 μg ABIN7487819
1 mg ABIN7446089
100 μg ABIN7487819
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL4 (Pascolizumab Biosimilar) antibody (ABIN7487819)
Target
IL4 (Pascolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for IL4 (Pascolizumab Biosimilar) antibodies
Mammalian Cells
Clonality
All clonalities for IL4 (Pascolizumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for IL4 (Pascolizumab Biosimilar) antibodies
This IL4 (Pascolizumab Biosimilar) antibody is un-conjugated
Application
All applications for IL4 (Pascolizumab Biosimilar) antibodies
ELISA
Grade
Research Grade
Product Details anti-IL4 (Pascolizumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Pascolizumab Biosimilar - Anti-IL4 mAb
Characteristics
Antibody Type: IgG1-kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for IL4 (Pascolizumab Biosimilar)
(hide)
Target
IL4 (Pascolizumab Biosimilar)
Target Type
Biosimilar
Background
SB-240683 Recombinant monoclonal antibody to IL4. Pascolizumab is a humanized monoclonal antibody for the treatment of asthma.
CAS-No
331243-22-2
Recently viewed
(hide)
Chat with us , powered by LiveChat